- Home
- WORX vs ONCO Comparison
WORX vs ONCO Comparison
Compare WORX & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- ONCO
- Stock Information
- Founded
- WORX N/A
- ONCO 2018
- Country
- WORX United States
- ONCO United States
- Employees
- WORX N/A
- ONCO N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- ONCO Health Care
- Exchange
- WORX Nasdaq
- ONCO Nasdaq
- Market Cap
- WORX 4.3M
- ONCO 4.3M
- IPO Year
- WORX N/A
- ONCO 2022
- Fundamental
- Price
- WORX $0.26
- ONCO $2.17
- Analyst Decision
- WORX
- ONCO
- Analyst Count
- WORX 0
- ONCO 0
- Target Price
- WORX N/A
- ONCO N/A
- AVG Volume (30 Days)
- WORX 41.1M
- ONCO 30.7K
- Earning Date
- WORX 11-12-2025
- ONCO 11-13-2025
- Dividend Yield
- WORX N/A
- ONCO N/A
- EPS Growth
- WORX N/A
- ONCO N/A
- EPS
- WORX N/A
- ONCO N/A
- Revenue
- WORX $2,784,479.00
- ONCO $1,223,751.00
- Revenue This Year
- WORX N/A
- ONCO N/A
- Revenue Next Year
- WORX N/A
- ONCO N/A
- P/E Ratio
- WORX N/A
- ONCO N/A
- Revenue Growth
- WORX N/A
- ONCO N/A
- 52 Week Low
- WORX $0.23
- ONCO $2.10
- 52 Week High
- WORX $2.94
- ONCO $179.35
- Technical
- Relative Strength Index (RSI)
- WORX 45.14
- ONCO 38.17
- Support Level
- WORX $0.24
- ONCO $2.17
- Resistance Level
- WORX $0.26
- ONCO $2.35
- Average True Range (ATR)
- WORX 0.03
- ONCO 0.20
- MACD
- WORX -0.00
- ONCO -0.02
- Stochastic Oscillator
- WORX 25.16
- ONCO 29.91
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.